Patient-reported outcomes in clinical studies of patients with hypertrophic cardiomyopathy.

ABSTRACT:

Objectives

This study aimed to characterize patient-reported outcomes (PROs) in registered clinical studies of participants with hypertrophic cardiomyopathy (HCM).

Background

Therapy for HCM is primarily targeted toward alleviation of symptoms and improvement in function and quality of life. Yet, the contemporary landscape of PROs in HCM clinical research has not been investigated.

Methods

ClinicalTrials.gov was queried to identify clinical studies of HCM that reported PROs as outcome measures. All studies of HCM as the disease condition were included, and PROs were identified using specific search terms in the Outcome Measures field. Study characteristics were collected and compared between those that did versus did not report PROs.

Results

From November 1987

SUBMITTER: Reza N 

PROVIDER: S-EPMC10543561 | biostudies-literature | 2023 Sep-Oct

REPOSITORIES: biostudies-literature